Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06383988 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources

Study acronym: CONNECT
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later across 2 updates Aug 30, 2026 → Dec 30, 2026
See other at-risk trials from Wake Forest University Health Sciences

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Primary and study completion pushed from Sep 30, 2026 to Dec 30, 2026 Show 5 more changesShow less
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 1 of 16 entries
    • Study description expanded, about 9 words
    • Site details revised at 2 of 25 sites
    • Publications: details revised at 1 of 1 entry
  2. Minor Primary and study completion pushed from Aug 30, 2026 to Sep 30, 2026v21
  3. Minor Primary completion pushed from Jun 30, 2026 to Aug 30, 2026
    • Study completion pushed from Jul 30, 2026 to Aug 30, 2026
    v20
  4. Minor Primary completion pushed from Apr 30, 2026 to Jun 30, 2026v19
  5. Minor Trial status: Enrolling by Invitation to Active, Not Recruiting
    • Enrollment target: 240 to 216
    v18
Show 16 earlier versionsHide 16 earlier versions
  1. Minor Primary completion date: Mar 1, 2026 to Apr 30, 2026
    • Study completion date: Jun 1, 2026 to Jul 30, 2026
    v17
  2. Minor Eligibility criteria expanded, about 11 wordsv16
  3. Minor Study sites: 23 to 25v15
  4. Minor Study sites: 29 to 23v14
  5. Minor Study description revisedv13
  6. Minor Primary completion date: Oct 1, 2025 to Mar 1, 2026
    • Study completion date: Jan 1, 2026 to Jun 1, 2026
    v12
  7. Minor Study sites: 27 to 29v11
  8. Minor Study sites: 24 to 27v10
  9. Minor 3 versions Re-verified since Nov 8, 2024, no change to tracked fieldsv7-v9
  10. Minor Study sites: 20 to 24
    • Start date: Oct 19, 2024 to Nov 11, 2024
    v6
  11. Notable Start date: Sep 19, 2024 to Oct 19, 2024
    • Study sites: 1 to 20
    v5
  12. Notable Start date: Jul 2, 2024 to Sep 19, 2024v4
  13. Minor Primary completion date: Apr 1, 2026 to Oct 1, 2025
    • Study completion date: Jun 1, 2026 to Jan 1, 2026
    • Eligibility criteria expanded, about 6 words
    v3
  14. Notable Trial status: Not Yet Recruiting to Enrolling by Invitationv2 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Oct 2025 to Apr 1, 2026
    • Study completion date: Jan 2026 to Jun 1, 2026
    • Start date changed from estimate of Jul 2024 to Jul 2, 2024
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Clinical trial that tests the feasibility of a web based caregiver support resource, along with caregiver navigation sessions for caregivers of patients with stage II-IV lung cancer. The Caregiver Oncology Needs Evaluation Tool (CONNECT) is a novel web-based intervention designed for the community oncology setting, to systematically connect lung cancer caregivers with tailored supportive care resources. Lung cancer caregivers provide critical and challenging care for their loved ones and are at risk for their own negative psychosocial and physical outcomes. Implementing the CONNECT program along with caregiver navigation may provide additional support to caregivers of patients with stage II-IV lung cancer.
Trial Details
NCT Number NCT06383988
Lead Sponsor Wake Forest University Health Sciences
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)
Stage II Lung Cancer, Stage III Lung Cancer, Stage IV Lung Cancer
Related terms Lung Neoplasms
Enrollment 216 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov